[Dilip Davda] NAGL is in the business of hybrid seeds manufacturing and marketing along with related bio-organic products. Based on its FY23 super earnings, the issue appears fully priced. Dilution of over 34% equity raise concern. Well-informed investors may consider an investment with a long-term perspective. Read detail review...

Nirman Agri Genetics IPO Review by Members

Nirman Agri Genetics IPO Reviews, analysis and views by popular members. Read Nirman Agri Genetics Ltd. IPO reviews by retail investors to find recommended ipo to buy.

Nirman Agri Genetics IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	0	0
%	0.00	0.00	0.00	0.00

Member	Review
No recommendation found. Be the first to post the recommendation.

Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.

Nirman Agri Genetics IPO Review & Recommendations

Nirman Agri Genetics IPO Review Summary from brokers and analysts

Nirman Agri Genetics IPO Review by Dilip Davda May apply

Nirman Agri Genetics IPO Review by Members

Nirman Agri Genetics IPO Review Summary by Members

Read more about Nirman Agri Genetics IPO